BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15110643)

  • 1. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
    Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
    Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early de novo neoplasia after renal transplantation].
    Veroux P; Veroux M; Puliatti C; Amodeo C; Macarone M; Cappello D; Caglià P
    Tumori; 2003; 89(4 Suppl):301-4. PubMed ID: 12903627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin malignancies in renal transplant recipients: a Brazilian center registry.
    Falsarella PM; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
    Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
    Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy in renal recipients.
    Samhan M; Al-Mousawi M; Donia F; Fathi T; Nasim J; Nampoory MR
    Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo tumors after liver transplantation: a single-institution experience.
    Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
    Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of posttransplantation malignancies compared with de novo tumors.
    Haberal AN; Süren D; Demirhan B; Bilezikçi B; Celasun B; Haberal M
    Transplant Proc; 2007 May; 39(4):1057-62. PubMed ID: 17524891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and types of malignancies in renal transplant recipients in Iraq.
    Altaee IK; Jaleel NA; Aljubury HM; Alshamaa IA; Gazala S
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):408-14. PubMed ID: 16970265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of malignancy following living donor kidney transplantation.
    Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
    Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
    Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
    Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies after kidney transplantation.
    Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
    Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [De novo neoplasms in transplant patients].
    Careaga-Reyna G; Argüero-Sánchez R
    Gac Med Mex; 1999; 135(1):1-4. PubMed ID: 10204306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.